CLU and ovarian cancer: Although our observations were consistent with previously reported ones that s-CLU mediates cisplatin-induced resistance in ovarian cancer [34], CLU expression was found not to be a prognostic factor among patients with advanced-stage (stage III/IV) ovarian cancer in our patient cohort (data not shown).